# MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

> **NCT00129155** · PHASE2 · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 30 (estimated)

## Conditions studied

- Hematological Malignancies
- Allogeneic Transplantation

## Interventions

- **DRUG:** treosulfan

## Key facts

- **NCT ID:** NCT00129155
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129155, "MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00129155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*